Curemark
Curemark is a socially driven biotechnology company focused on the treatment of Autism and other neurological disorders.
12/08/2020
Bench to Biopharma: Our mission of catalyzing the development of treatments for and is incomplete without the participation of our and partners.
synchronysymposium.com
Our thanks to A. Stewart Campbell of Axial Therapeutics for chairing our Dec 6, 2020 afternoon session on clinical trials and therapeutics on the path to FDA approval.
Honored to host our other industry speakers:
Kevin Sanders, Global Head of Neurodevelopment- Neuroscience, Product Development, Roche-Genentech
Véronique Crutel, Project Director, Neuropsychiatry Center for Therapeutic Innovation, Servier
Gahan Pandina, Senior Director, Venture Leader, Janssen Research & Development
Dr. Joan Fallon, Founder and CEO, Curemark
Dr. Rosa Krajmalnik-Brown and Dr. James Adams, Arizona State University
Click here to claim your Sponsored Listing.
Category
Contact the business
Telephone
Website
Address
800 Westchester Avenue
Rye Brook, NY
10573